Selective cyclooxygenase-2 inhibitor
Hettich, M.; Thomae, K.
Der Internist 38(10): 1007
1997
ISSN/ISBN: 0020-9554 PMID: 9432492 Document Number: 483209
Document emailed within 1 workday
Related Documents
Kawata, K.; Takeyoshi, I.; Iwanami, K.; Sunose, Y.; Tsutsumi, H.; Ohwada, S.; Matsumoto, K.; Morishita, Y. 2003: The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury Hepato-Gastroenterology 50(54): 1970-1974Depré, M.; Van Hecken, A.; Verbesselt, R.; De Lepeleire, I.; Schwartz, J.; Porras, A.; Larson, P.; Lin, C.; De Schepper, P.J. 1998: Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man International Journal of Clinical Pharmacology Research 18(2): 53-61
Bolten, W.W. 2003: In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor MMW Fortschritte der Medizin 145(5): 9
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Penna, P. 2004: Patterns of cyclooxygenase-2 inhibitor utilization Managed Care Interface 17(7): 19-20
Kawai, S. 2002: Recent development of selective cyclooxygenase-2 inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2370-2377
Palmer, R.H. 2000: Cyclooxygenase 2 selective agents and upper gastrointestinal disease JAMA 283(15): 1961-1962
Paulson, S.K.; Engel, L.; Reitz, B.; Bolten, S.; Burton, E.G.; Maziasz, T.J.; Yan, B.; Schoenhard, G.L. 1999: Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(10): 1133-1142
Nicoll-Griffith, D.A.; Falgueyret, J.P.; Silva, J.M.; Morin, P.E.; Trimble, L.; Chan, C.C.; Clas, S.; Leger, S.; Wang, Z.; Yergey, J.A.; Riendeau, D. 1999: Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(3): 403-409
Muraki, I. 2001: Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate Hokkaido Journal of Medical Science 76(2): 57-70
Falkowski, M.; Skogstad, S.; Shahzidi, S.; Smedsröd, B.; Sveinbjörnsson, B. 2003: The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma Anticancer Research 23(3b): 2303-2308
Depré, M.; Van Hecken, A.; Verbesselt, R.; Verpooten, G.A.; Arnout, J.; Brunner, F.; Jurgens, A.; Pousset, V.; Chow, A.; Baldauf, C.; Vermylen, J.; De Broe, M.; De Schepper, P.J. 1996: Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man International Journal of Clinical Pharmacology Research 16(1): 1-8
Jin, X-feng.; Tong, J-lu.; Ran, Z-hua. 2007: Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis Zhonghua Yi Xue Za Zhi 87(28): 1958-1961
Sherer, Y.; Bar-Dayan, Y.; Shoenfeld, Y. 1997: Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs Harefuah 132(6): 411-416
Langman, M.J.S.; Eichler, H.G.; Mavros, P.; Watson, D.J.; Kong, S.X. 2004: Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs International Journal of Clinical Pharmacology and Therapeutics 42(5): 260-266
Kobayashi, M.; Takeyoshi, I.; Kurabayashi, M.; Matsumoto, K.; Morishita, Y. 2007: The effects of a cyclooxygenase-2 inhibitor, FK3311, on total hepatic ischemia-reperfusion injury of the rat Hepato-Gastroenterology 54(74): 522-526
Sincholle, D.; Bertez, C.; Legrand, A.; Conduzorgues, J.P.; Bonne, C. 1985: Anti-inflammatory activity of a dual inhibitor of cyclooxygenase and lipoxygenase pathways, CBS-1108 (2-acetylthiophene-2-thiazolylhydrazone) Arzneimittel-Forschung 35(8): 1260-1263
Yin, L.; Wei, L.; Qu, Q.; Guo, X. 2007: Experimental Studies on Cyclooxygenase-2 Inhibitor Induced Cervical Cancer Hela Cell Apoptosis and its Molecular Mechanism Journal of Reproduction and Contraception 18(4): 271-278
Karateev, A.E. 2014: Selective cyclooxygenase-2 inhibitors and protected nonsteroidal anti-inflammatory agents: two methods for the prevention of iatrogenic complications Klinicheskaia Meditsina 92(8): 54-61
Takeuchi, K.; Suzuki, K.; Yamamoto, H.; Araki, H.; Mizoguchi, H.; Ukawa, H. 1998: Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 49(4): 501-513